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g.2012.0Abstract Synthetic progestins and estrogens have been reported to be toxic in various experimen-
tal models. Their prolonged use has been reported to induce cancer in humans. In the present study
the effects of oral contraceptives were studied among users using chromosomal aberrations, sister
chromatid exchanges and DNA damage as a parameter, in cultured human peripheral blood lym-
phocytes. The study was performed on 25 women (users) and 25 age match controls. No signiﬁcant
difference was observed in chromosomal aberrations and DNA damage. A signiﬁcant increase was
observed in sister chromatid exchanges (SCEs) Cell among users. The results obtained and the risk
of oral contraceptives (OCs) genotoxicity have been discussed.
 2012 Ain Shams University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Oral contraceptives are the combination of estrogen and
progesterone. They are used to treat various hormonal
disturbances, premenstrual syndrome and ovarian cysts [1].
The composition of pills varies from country to country due
to the responsiveness variation from individual to individual
or one population to another [2]. Earlier reports suggest the
genotoxic effects of synthetic progestins in cultured humandiffmail.com (Y.H. Siddique).
Shams University.
g by Elsevier
y. Production and hosting by Elsev
6.002peripheral blood lymphocytes [3–7]. In these studies the geno-
toxic effects were observed at very high doses and, the reactive
oxygen species (ROS) was suggested as a causative agent for
the genotoxic damage [8,9]. The conversion of estrogen into
catechol estrogens and quinines, via redox reactions causes
oxidative damage to DNA [5,10]. There are both positive as
well as negative reports regarding the genotoxic effects of
estrogens and synthetic progestins [11–13]. In the present study
an attempt has been made to investigate the possible genotoxic
effects among oral contraceptives (OCs) users (females) by
using chromosomal aberrations, sister chromatid exchanges
and DNA damage as a parameter.ier B.V. All rights reserved.
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302 F. Naz et al.2. Subjects and methods
2.1. Chemicals
RPMI 1640, fetal calf serum, phytohaemagglutinin-M, antibi-
otic-antimycotic mixture (Invitrogen); 5-bromo-2-deoxyuri-
dine, Giemsa stain (Merck, India), TrisÆHCl, EDTA, Triton-
X, Trichloro acetic acid and diphenylamine, colchicine (SRL,
India).2.2. Human lymphocyte culture
A sample of heparinized venous blood was obtained from 25
women taking an OCs preparation containing levonorgestrel
and ethinylestradiol as a content for 12 months as a means of
contraception following their ﬁrst pregnancy. Age matched
healthy 25 controls were evaluated along with the above sub-
jects. A written informed consent was obtained from all sub-
jects. The mean age of 25 women using OCs was 28.5 years
and of the 25 controls was 27.5 years. Individuals answered a
questionnaire relating to lifestyle factors. The OC users were
not having any other addictions such as smoking, alcohol
drinking etc. nor have any history of disease. Brieﬂy, heparin-
ized blood sample (0.5 ml), was obtained from each female
and was placed in a sterile cultured tube containing 7 ml of
RPMI 1640 medium, supplemented with fetal calf serum
(1.0 ml), antibiotic–antimycotic mixture (1.0 ml) and phytohae-
magglutinin-M (0.1 ml). The culture tubes were placed in the
incubator at 37 C for 48 h [14].2.3. Chromosomal aberration analysis
After 47 h, an amount of 0.2 ml of colchicine (0.2 lg/ml) was
added to the culture tubes. Cells were centrifuged at 800 g for
10 min. The supernatant was removed and 8 ml of pre
warmed (37 C) 0.075 M KCl (hypotonic solution) was
added. Cells were re-suspended and incubated at 37 C for
15 min. The supernatant was removed by centrifugation, at
800 g for 10 min, and subsequently 5 ml of chilled ﬁxative
(methanol–glacial acetic acid; 3:1) was added. The ﬁxative
was removed by centrifugation and the procedure was re-
peated twice. The cells were stained in 3% Giemsa solution
in phosphate buffer (pH 6.8) for 15 min. About, 300 meta-
phases were examined for the occurrence of different types
of abnormality. Criteria to classify different types of aberra-
tion were in accordance with the recommendation of Envi-
ronment Health Criteria 48 for Environment Monitoring of
Human Population [15].
2.4. Sister chromatid exchanges
For sister chromatid exchange analysis, bromo deoxyuridine
(10 lg/ml) was added at the beginning of the culture and
the mitotic arrest was attempted, 1 h prior to harvesting by
adding 0.2 ml of colchicine (0.2 lg/ml). Hypotonic treatment
and ﬁxation were performed as described for chromosomal
aberration analysis. The sister chromatid average was taken
from an analysis of metaphase during second cycle of divi-
sion. A total of 25 well spread metaphases were scored per
individual [16].
Genotoxic damage in cultured human peripheral blood lymphocytes of oral contraceptive users 3032.5. Quantitative assay for DNA fragmentation
Quantitative assay for DNA fragmentation was performed
according to the protocol of Burton [17]. After incubation of
48 h, the cell suspension containing 1–10 · 106 cells in a 1 ml
volume was prepared for each donor. About, 0.8 ml of cell sus-
pension was transferred to a micro centrifuge tube and 0.7 ml
of ice cold lysis buffer (5 mM Tris Cl, pH 8.0/20 mM EDTA/
0.5% (v/v Triton X-100) was added. The tubes were vortexed
and allowed to lyse for 30 min at 4 C. The tubes were centri-
fuged for 15 min at 15,000 g (4 C) and the supernatant was
transferred to a labeled conical glass tube. About 0.65 ml of
5% trichloroacetic acid (TCA) was added to the pellet in a mi-
cro centrifuge tube and 1.5 ml of 10% TCA to the sample in a
labeled glass tube. The sample was precipitated overnight at
4 C. The tubes were centrifuged for 10 min at 2500 g at room
temperature and the supernatant was removed and about
0.65 ml of 5% TCA was added to the pellet. The tubes were
boiled for 15 min at 100 C in a water bath. After cooling
down to room temperature the sample was centrifuged at
2500 g for 5 min. About 0.5 ml of each supernatant (from both
glass and micro centrifuge tubes) was added to the labeled
glass tube. About, 1 ml of diphenylamine reagent was added
to each tube and was incubated for 4 h at 37 C [18]. Finally
the absorbances were noted at 600 nm in a spectrophotometer
and the results were expressed in the percentage of DNA frag-
mented as follows:
%Fragmented DNA ¼ absorbance of supernatant
absorbance of supernatantþ pelletTable 2 Distribution of Sister chromatid exchanges (SCEs)
among women using oral contraceptives (OCs).
Subjects SCE per cell
OC users Control
1 4.2 2.3
2 4.1 2.5
3 4.3 2.9
4 3.9 2.7
5 3.5 2.4
6 3.6 2.3
7 3.7 2.6
8 3.3 3.1
9 3.7 2.2
10 3.8 2.3
11 4.1 2.4
12 4.0 2.5
13 3.2 3.2
14 3.2 2.9
15 3.3 2.8
16 4.2 2.7
17 4.1 3.2
18 4.3 2.2
19 4.4 2.8
20 4.0 2.7
21 4.3 2.4
22 4.2 2.3
23 4.1 2.8
24 3.9 2.1
25 4.4 3.3
Mean ± SE 3.91 ± 0.076* 2.62 ± 0.068
* P> 0.005 (Signiﬁcant with respect to control).2.6. Statistical analysis
Student’s t-test was used for the analysis of data obtained for
chromosomal aberrations and sister chromatid exchanges and
v2 (Chi-square) was applied for the analysis of DNA damage.
3. Results and discussion
The frequency of cells with aberration in OC users was almost
similar to their age matched controls. Gaps and breaks of chro-
mosome as well as chromatid were observed, but dicentric, ex-
changes and rearrangements were not observed. The mean
values obtained were not statistically signiﬁcant (Table 1). A
signiﬁcant difference (P> 0.005) in the number of SCEs/cell
was observed between OC users (3.9 ± 0.076) and their age
matched control (2.62 ± 0.068) (Table 2). The mean value for
the DNA damage was (0.1172 ± 0.0020) in OC users and
(0.1148 ± 0.0025) in controls. The values were not statistically
signiﬁcant (Table 3). The results of the present study suggest
that the OC users have signiﬁcantly higher frequencies of
SCEs/cell, but the CAs and DNA damage were not signiﬁcant.
An increase in the frequencies of SCEs and CAs has been re-
ported during pregnancy [19,20]. The concentration of the
estrogens is increased during pregnancy, which may be the pos-
sible reason of an increase in SCEs [21]. Earlier studies per-
formed on the genotoxic potential of steroids have shown to
cause chromosomal damage, induction of SCEs and formation
of endogenous adducts [7,22–24]. The results of the present
study show that the OCs are not potent in inducing DNATable 3 Estimation of DNA damage among oral contracep-
tives (OCs) users and non-users.
Subjects OC users Control
1 0.11 0.10
2 0.12 0.11
3 0.12 0.12
4 0.13 0.11
5 0.12 0.12
6 0.10 0.13
7 0.11 0.13
8 0.13 0.12
9 0.14 0.11
10 0.12 0.09
11 0.11 0.08
12 0.10 0.11
13 0.11 0.12
14 0.12 0.11
15 0.11 0.12
16 0.13 0.13
17 0.13 0.11
18 0.12 0.12
19 0.12 0.12
20 0.12 0.13
21 0.11 0.12
22 0.12 0.11
23 0.11 0.10
24 0.10 0.12
25 0.12 0.13
Mean ± SE 0.1172 ± 0.0020 0.1148 ± 0.00252
P> 0.005 NS (Non signiﬁcant).
304 F. Naz et al.damage/chromosomal aberrations, but are able to increase the
number of SCEs/cell. The study performed by Biri et al. [25] also
showed the increase in SCEs/Cell in OC users. The SCEs are the
cytological manifestation of interchanges between DNA repli-
cation products at apparently homologous loci. It is more sen-
sitive indicator of genotoxic effects than structural aberrations
[26,27]. The induction of SCE is also correlated with the induc-
tion of cancer [28]. Besides various reports on the genotoxicity
of steroids some of the progestogens have been studied in short
and long term toxicology studies in rodents and dogs or mon-
keys for their carcinogenic activity, no signiﬁcant or unusual
toxicities were reported [29]. In some cases the oral contracep-
tives have also been suggested to be having a role in prevent-
ing ovarian cancer by both suppressing ovulation and altering
the tumor promoting milieu [30]. The results obtained in the
present study are contrary to the studies performed by other
workers [13,31,32]. This may be due to the new hormonal
formulations and preparations developed in an attempt to re-
duce the adverse effects of OCs, such as the reduction in the
estrogen content. Estrogen such as ethinylestradiol, in the li-
ver undergoes aromatic hydroxylation and the product, 4-
hydroxyestrone, 3,4-dihydroxy 1,3,5 (10)–oestratien-17-one
(4-OHE) is carcinogenic in male Syrian golden hamster kid-
ney tumor model [33,34]. The genotoxic potential of steroids
is determined by the metabolic conditions in the test system
and the human body. The extrapolation from the experimen-
tal data to humans is not only difﬁcult but also complex. The
most of the studies conducted for genotoxic potential of ste-
roids involve the concentration in microgram per ml range
whereas the therapeutic plasma concentration ranges from
nanogram or picogram per ml [7]. The present study was con-
ducted on the women taking OCs for one year and the in-
crease in SCEs may be due to the variable hormonal proﬁle
among them. Further, the occupation and work place, poly-
morphic metabolizing genes and efﬁciency of DNA repair can
also affect the response against OCs.Acknowledgements
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